Get in touch
Close
Contacts

1309 Coffeen Avenue
STE 1200, Sheridan,
Wyoming 82801, USA

+1 (307) 459 4588

contact@exatonix.com

    AI-Driven Bio-Active Delivery: How Exatonix is Powering Cleanical Lab’s Dermatological Research

    Exatonix
    cleanical-lab-exatonix-colab

    AI-Driven Bio-Active Delivery: How Exatonix is Powering Cleanical Lab’s Dermatological Research

    The intersection of artificial intelligence and bio-engineering has produced some of the most exciting breakthroughs in dermatological science. At Exatonix, we are proud to announce the results of our collaborative research engagement with Cleanical Lab, a Swiss-based bio-tech company specializing in clinically validated, targeted skincare solutions. The partnership demonstrates how AI consulting and computational modeling can directly accelerate the development of real-world medical-grade consumer products.

    The Challenge: Precision Delivery at the Micro Scale

    Cleanical Lab’s flagship product — the 5-patch Precision-Delivery Bio-Active Nanoneedle — relies on 1,140 ultra-fine microneedles per patch to create micro-channels in the skin, enabling deep delivery of hyaluronic acid beneath the epidermal surface. The engineering challenge is formidable: each needle must dissolve at a rate calibrated to the individual’s skin composition, hydration level, and the specific active compound being delivered. Too fast, and the active ingredient dissipates before reaching the target depth. Too slow, and the patient experiences suboptimal results over the treatment window.

    Traditional R&D approaches for this type of bio-active delivery system rely on iterative physical prototyping and clinical trial-and-error — a process that can take months per formulation variant and cost tens of thousands of Swiss francs per cycle.

    The AI Solution: Computational Modeling of Compound Delivery Chains

    Exatonix deployed a custom neural network architecture to model the dissolution kinetics of the microneedle matrix under variable dermal conditions. By training on Cleanical Lab’s existing clinical trial data — including before-and-after imaging, patient feedback surveys, and spectroscopic measurements of hyaluronic acid absorption rates — our AI system was able to identify optimal needle geometry and compound density configurations that human researchers had not previously explored.

    The model incorporated multiple data streams:

    – Spectroscopic absorption data from clinical trials measuring how quickly hyaluronic acid penetrated the epidermal layer across 50+ test subjects
    – Patient-reported outcomes including reduction in under-eye bags, expression line smoothing, and skin firmness ratings over 2-week and 4-week protocols
    – Dermatological imaging comprising high-resolution before-and-after comparisons of the under-eye and crow’s feet areas
    – Biomechanical skin models accounting for age, hydration, and skin elasticity variables

    The result was a predictive framework that could simulate thousands of formulation permutations in hours rather than the weeks required for physical prototyping. This allowed Cleanical Lab’s bio-engineering team to narrow their next-generation formulation candidates from over 200 possibilities to 6 high-confidence variants — all before a single physical patch was manufactured.

    Clinical Impact: Measurable Results

    The AI-optimized formulations have already shown promising results in Cleanical Lab’s follow-up clinical assessments. Patient feedback collected through the Cleanical Lab platform reports:

    – Under-eye bags: Verified users noted “huge improvement” after completing multi-patch protocols over 8+ weeks
    – Active absorption: Practicing clinical dermatologists observed enhanced dissolution rates with “excellent hydration delivery directly beneath the epidermal layer with no surface trauma”
    – Expression lines: Users on the 4-week protocol reported visibly softened crow’s feet and brighter under-eye appearance

    The 4.7-star average patient rating — with 100% of reviewers recommending the product — validates the AI-assisted optimization approach as a meaningful contributor to clinical efficacy.

    What This Means for the Industry

    This collaboration between Exatonix and Cleanical Lab represents a broader trend: the democratization of AI-powered research tools for mid-size biotech and consumer health companies. Historically, the kind of computational modeling and neural network-driven formulation optimization used in this project was the exclusive domain of large pharmaceutical companies with dedicated in-house AI teams.

    Exatonix’s consulting model changes that equation. By providing AI infrastructure, model training, and domain-specific expertise on an engagement basis, we enable companies like Cleanical Lab — focused, science-driven organizations with deep clinical expertise but limited computational resources — to leverage the same AI capabilities that are reshaping the pharmaceutical industry.

    The implications extend beyond skincare. The same AI-driven delivery optimization framework can be applied to:

    – Transdermal drug delivery systems for pain management and hormone therapy
    – Wearable biosensor calibration for continuous health monitoring
    – Personalized medicine protocols that adapt compound delivery to individual patient profiles

    Looking Forward

    Exatonix is expanding its AI consulting services for the bio-tech and dermatological sectors. The Cleanical Lab engagement has proven that AI-driven research can meaningfully reduce time-to-market for clinically validated products while improving patient outcomes. We are currently in discussions with several additional bio-engineering firms to deploy similar AI optimization frameworks.

    For companies interested in exploring how AI can accelerate their research and development pipelines, Exatonix offers comprehensive consulting services ranging from initial computational modeling to full-scale AI infrastructure deployment. Our team specializes in bridging the gap between cutting-edge AI technology and practical, results-driven business applications.

    Exatonix provides AI consulting, high-power computing infrastructure, and neural network integration services to businesses worldwide. Headquartered in Sheridan, Wyoming, we help organizations unlock the full potential of artificial intelligence for their specific industry challenges.

    Phil Daniels – CEO Exatonix

    Cleanical Lab is a Swiss-based bio-tech company specializing in advanced bio-engineering for targeted dermatological solutions. Their clinically validated microneedling patches combine hyaluronic acid delivery with precision nanoneedle technology for safe, effective at-home treatment. Learn more at cleanical-lab.com.

    We work with businesses to implement cutting-edge energy optimization strategies that align with their HPC needs. This includes leveraging advanced cooling systems, optimizing energy usage during peak computation times, and integrating AI-powered energy management solutions. With Exatonix, you can achieve world-class computing performance without sacrificing sustainability or cost-efficiency.

    Are you ready to explore how high-power computing can transform your business? Contact Exatonix today and discover how our consulting services can help you build and scale the infrastructure you need to succeed in a fast-paced, data-driven world.